| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.35 | 0.1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.31 | 0.1 |